{"brief_title": "Efficacy and Safety In Poorly Controlled Type 2 Diabetics", "brief_summary": "The purpose of this study is to gain safety and efficacy information in patients with type 2 diabetes, who have not previously taken any oral antidiabetic medications, and who have an HbA1c value of greater than or equal to 10%, despite diet and exercise.", "condition": "Diabetes Mellitus, Type 2", "intervention_type": "Drug", "intervention_name": "rosiglitazone", "criteria": "Inclusion criteria: - Type 2 diabetes - Drug-naive. - Laboratory test result for HbA1c of greater than or equal to 10%. - Written informed consent. Exclusion criteria: - Prior use of antidiabetic medications within 3 months of screening. - Fluid retention (edema). - Significant liver disease. - Low red blood cells (anemia). - Severe or unstable angina (chest pain). - Congestive heart failure. - Severe high blood pressure. - Alcohol or drug abuse. - Other inclusion or exclusion criteria to be determined by the physician and study sponsor.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "70 Years", "healthy_volunteers": "No", "id": "NCT00044460.xml"}